|
1
|
Silva NA, Sousa N, Reis RL and Salgado AJ:
From basics to clinical: A comprehensive review on spinal cord
injury. Prog Neurobiol. 114:25–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brommer B, Engel O, Kopp MA, Watzlawick R,
Müller S, Prüss H, Chen Y, DeVivo MJ, Finkenstaedt FW, Dirnagl U,
et al: Spinal cord injury-induced immune deficiency syndrome
enhances infection susceptibility dependent on lesion level. Brain.
139:692–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siddall PJ, McIndoe L, Austin P and
Wrigley PJ: The impact of pain on spiritual well-being in people
with a spinal cord injury. Spinal Cord. 55:105–111. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmed MM, King KC, Pearce SM, Ramsey MA,
Miranpuri GS and Resnick DK: Novel targets for spinal cord injury
related neuropathic pain. Ann Neurosci. 18:162–167. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hooshmand MJ, Galvan MD, Partida E and
Anderson AJ: Characterization of recovery, repair, and inflammatory
processes following contusion spinal cord injury in old female
rats: Is age a limitation? Immun Ageing. 11:152014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garshick E, Stolzmann KL, Gagnon DR, Morse
LR and Brown R: Systemic inflammation and reduced pulmonary
function in chronic spinal cord injury. PM R. 3:433–439. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gris D, Hamilton EF and Weaver LC: The
systemic inflammatory response after spinal cord injury damages
lungs and kidneys. Exp Neurol. 211:259–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pillai RS: MicroRNA function: Multiple
mechanisms for a tiny RNA? RNA. 11:1753–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
11
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng W and Feng Y: MicroRNAs in neural
cell development and brain diseases. Sci China Life Sci.
54:1103–1112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bian S and Sun T: Functions of noncoding
RNAs in neural development and neurological diseases. Mol
Neurobiol. 44:359–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Papagiannakopoulos T and Kosik KS:
MicroRNAs: Regulators of oncogenesis and stemness. BMC Med.
6:152008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Blandino G, Fazi F, Donzelli S, Kedmi M,
Sas-Chen A, Muti P, Strano S and Yarden Y: Tumor suppressor
microRNAs: A novel non-coding alliance against cancer. FEBS Lett.
588:2639–2652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Palanichamy JK and Rao DS: miRNA
dysregulation in cancer: Towards a mechanistic understanding. Front
Genet. 5:542014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Kim S and Kim IM: Regulation of
metastasis by microRNAs in ovarian cancer. Front Oncol. 4:1432014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Othman N and Nagoor NH: The role of
microRNAs in the regulation of apoptosis in lung cancer and its
application in cancer treatment. Biomed Res Int. 2014:3180302014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han C, Yu Z, Duan Z and Kan Q: Role of
microRNA-1 in human cancer and its therapeutic potentials. Biomed
Res Int. 2014:4283712014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu NK, Wang XF, Lu QB and Xu XM: Altered
microRNA expression following traumatic spinal cord injury. Exp
Neurol. 219:424–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roberto GM, Lira RC, Delsin LE, Vieira GM,
Silva MO, Hakime RG, Yamashita ME, Engel EE, Scrideli CA, Tone LG
and Brassesco MS: microRNA-138-5p as a worse prognosis biomarker in
pediatric, adolescent, and young adult osteosarcoma. Pathol Oncol
Res. Mar 12–2019.doi: 10.1007/s12253-019-00633-0. [Epub ahead of
print].
|
|
22
|
He Z, Ruan X, Liu X, Zheng J, Liu Y, Liu
L, Ma J, Shao L, Wang D, Shen S, et al:
FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates
angiogenesis in Glioma. J Exp Clin Cancer Res. 38:652019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu D, Gu L, Li Z, Jin W, Lu Q and Ren T:
MiR-138-5p suppresses lung adenocarcinoma cell
epithelial-mesenchymal transition, proliferation and metastasis by
targeting ZEB2. Pathol Res Pract. 215:861–872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma J, Zhang Y, Ji H, Chen L, Chen T, Guo
C, Zhang S, Jia J and Niu P: Overexpression of miR-138-5p
suppresses MnCl2 -induced autophagy by targeting SIRT1 in SH-SY5Y
cells. Environ Toxicol. 34:539–547. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nogueiras R, Habegger KM, Chaudhary N,
Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT
and Tschöp MH: Sirtuin 1 and sirtuin 3: Physiological modulators of
metabolism. Physiol Rev. 92:1479–1514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
da Cunha MSB and Arruda SF:
Tucum-do-Cerrado (Bactris setosa Mart.) may promote anti-aging
effect by upregulating SIRT1-Nrf2 pathway and attenuating oxidative
stress and inflammation. Nutrients. 9:E12432017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rada P, Pardo V, Mobasher MA,
García-Martínez I, Ruiz L, González-Rodríguez Á, Sanchez-Ramos C,
Muntané J, Alemany S, James LP, et al: SIRT1 controls acetaminophen
hepatotoxicity by modulating inflammation and oxidative stress.
Antioxid Redox Signal. 28:1187–1208. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan SH, Hung CH, Shih JY, Chu PM, Cheng
YH, Lin HC and Tsai KL: SIRT1 inhibition causes oxidative stress
and inflammation in patients with coronary artery disease. Redox
Biol. 13:301–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng YY, Kao CL, Ma HI, Hung CH, Wang CT,
Liu DH, Chen PY and Tsai KL: SIRT1-related inhibition of
pro-inflammatory responses and oxidative stress are involved in the
mechanism of nonspecific low back pain relief after exercise
through modulation of Toll-like receptor 4. J Biochem. 158:299–308.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roberts TT, Leonard GR and Cepela DJ:
Classifications in brief: American spinal injury association (ASIA)
impairment scale. Clin Orthop Relat Res. 475:1499–1504. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American Physiological
Society. Physiologist. 39:199208–199211. 1996.
|
|
32
|
Xin DQ, Hu ZM, Huo HJ, Yang XJ, Han D,
Xing WH, Zhao Y and Qiu QH: Schisandrin B attenuates the
inflammatory response, oxidative stress and apoptosis induced by
traumatic spinal cord injury via inhibition of p53 signaling in
adult rats. Mol Med Rep. 16:533–538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan Y, Yu L, Zhang C, Chen K, Lu J and Tan
L: miRNA-146a attenuates inflammation in an in vitro spinal cord
injury model via inhibition of TLR4 signaling. Exp Ther Med.
16:3703–3709. 2018.PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang C, Pan Y, Cheng B, Chen J and Bai B:
Identification of conserved and novel microRNAs in cerebral
ischemia-reperfusion injury of rat using deep sequencing. J Mol
Neurosci. 54:671–683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan G, An Y, Tao J, Wang Y, Zhou Q, Yang R
and Liang Q: MicroRNA-129-5p alleviates spinal cord injury in mice
via suppressing the apoptosis and inflammatory response through
HMGB1/TLR4/NF-κB pathway. Biosci Rep. 40:BSR201933152020.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun F, Li SG, Zhang HW, Hua FW, Sun GZ and
Huang Z: MiRNA-411 attenuates inflammatory damage and apoptosis
following spinal cord injury. Eur Rev Med Pharmacol Sci.
24:491–498. 2020.PubMed/NCBI
|
|
38
|
Weishaupt N, Silasi G, Colbourne F and
Fouad K: Secondary damage in the spinal cord after motor cortex
injury in rats. J Neurotrauma. 27:1387–1397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang B, Wang D, Yan T and Yuan H:
MiR-138-5p promotes TNF-α-induced apoptosis in human intervertebral
disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt
signaling. Exp Cell Res. 345:199–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tian S, Guo X, Yu C, Sun C and Jiang J:
miR-138-5p suppresses autophagy in pancreatic cancer by targeting
SIRT1. Oncotarget. 8:11071–11082. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bank M, Stein A, Sison C, Glazer A, Jassal
N, McCarthy D, Shatzer M, Hahn B, Chugh R, Davies P and Bloom O:
Elevated circulating levels of the pro-inflammatory cytokine
macrophage migration inhibitory factor in individuals with acute
spinal cord injury. Arch Phys Med Rehabil. 96:633–644. 2015.
View Article : Google Scholar : PubMed/NCBI
|
